PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Phenylpropanolamine→

Phenylpropanolamine PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
14838-15-4
Molecular formula
C9H13NO
Molecular weight
151.21 g/mol
Drug class
Sympathomimetic aminepredominantly indirect adrenergic agonist and nasal decongestant
Mechanism of action
Primarily promotes norepinephrine release from sympathetic nerve terminals and also has direct agonist activity at adrenergic receptors. Alpha-adrenergic activity causes vasoconstriction of nasal mucosal vessels; beta-adrenergic effects may also occur.
Indications / reported uses
  • Historically used as an oral or topical nasal decongestant in some jurisdictions; current availability and permitted indications vary because of safety-related regulatory restrictions.
  • It has also been used as an appetite suppressant historically; this is not presented as a current routine therapeutic indication.

Sources: https://www.ncbi.nlm.nih.gov/mesh?Cmd=DetailsSearch&Term=%22Phenylpropanolamine%22%5BMeSH+Terms%5D · https://meshb.nlm.nih.gov/record/ui?dcmsLinks=true&ui=D010665 · https://pubchem.ncbi.nlm.nih.gov/compound/10297

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Phenylpropanolamine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Phenylpropanolamine Permitted Daily Exposure (PDE) report (the Phenylpropanolamine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Phenylpropanolamine Occupational Exposure Limit (OEL) report (the Phenylpropanolamine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.